Tivity Health Inc (NASDAQ:TVTY) has earned an average rating of “Buy” from the twelve analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $32.63.

TVTY has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $40.00 price target on shares of Tivity Health in a research note on Wednesday, February 20th. ValuEngine downgraded Tivity Health from a “sell” rating to a “strong sell” rating in a research note on Monday, January 7th. BidaskClub raised Tivity Health from a “sell” rating to a “hold” rating in a research note on Tuesday, April 9th. Zacks Investment Research downgraded Tivity Health from a “buy” rating to a “hold” rating in a research note on Thursday, January 10th. Finally, SunTrust Banks dropped their price target on Tivity Health to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, February 20th.

Shares of NASDAQ:TVTY traded up $0.19 during midday trading on Friday, reaching $20.05. The company’s stock had a trading volume of 1,638,362 shares, compared to its average volume of 1,521,605. The company has a market capitalization of $955.38 million, a price-to-earnings ratio of 8.57, a P/E/G ratio of 0.83 and a beta of 1.01. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.96 and a quick ratio of 0.96. Tivity Health has a fifty-two week low of $16.25 and a fifty-two week high of $41.46.

Tivity Health (NASDAQ:TVTY) last posted its quarterly earnings results on Tuesday, February 19th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.57 by $0.16. Tivity Health had a return on equity of 30.19% and a net margin of 16.30%. The business had revenue of $153.04 million for the quarter, compared to the consensus estimate of $153.66 million. Analysts anticipate that Tivity Health will post 2.33 EPS for the current year.

In related news, Director Bradley S. Karro acquired 2,900 shares of the stock in a transaction dated Friday, March 22nd. The stock was purchased at an average cost of $16.54 per share, with a total value of $47,966.00. Following the completion of the purchase, the director now directly owns 24,696 shares in the company, valued at approximately $408,471.84. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Sara Finley acquired 2,000 shares of the stock in a transaction dated Wednesday, March 20th. The stock was bought at an average cost of $17.25 per share, with a total value of $34,500.00. The disclosure for this purchase can be found here. 1.64% of the stock is currently owned by corporate insiders.

Several institutional investors have recently modified their holdings of TVTY. JPMorgan Chase & Co. raised its stake in shares of Tivity Health by 91.3% in the third quarter. JPMorgan Chase & Co. now owns 2,545,523 shares of the company’s stock worth $81,838,000 after purchasing an additional 1,214,918 shares during the last quarter. BlackRock Inc. raised its stake in shares of Tivity Health by 13.5% in the third quarter. BlackRock Inc. now owns 5,948,356 shares of the company’s stock worth $191,239,000 after purchasing an additional 709,730 shares during the last quarter. Millennium Management LLC raised its stake in shares of Tivity Health by 291.6% in the fourth quarter. Millennium Management LLC now owns 867,656 shares of the company’s stock worth $21,527,000 after purchasing an additional 646,096 shares during the last quarter. Norges Bank bought a new position in shares of Tivity Health in the fourth quarter valued at approximately $12,171,000. Finally, Clearbridge Investments LLC grew its holdings in shares of Tivity Health by 966,500.0% in the third quarter. Clearbridge Investments LLC now owns 386,640 shares of the company’s stock valued at $12,430,000 after acquiring an additional 386,600 shares in the last quarter.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Further Reading: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.